Experience with the management of patients with therapy-resistant Hodgkin's disease
Berényi, E.; Szegedi, G.
Orvosi Hetilap 125(45): 2737-2740; 2743
1984
ISSN/ISBN: 0030-6002 PMID: 6548560 Document Number: 228649
Document emailed within 1 workday
Related Documents
Federico, M.; Clò, V.; Carella, A.M. 1996: High-dose therapy autologous stem cell transplantation vs conventional therapy for patients with advanced Hodgkin's disease responding to first-line therapy: analysis of clinical characteristics of 51 patients enrolled in the HD01 protocol. EBMT/ANZLG/Intergroup HD01 Trial Leukemia 10 Suppl. 2: S69-S71Geissler, K.; Gisslinger, H.; Knöbl, P.; Sperr, W.; Valent, P.; Dieckmann, K.; Chott, A.; Pötter, R.; Lechner, K.; Jäger, U. 2000: Efficacy of standard treatment in patients with Hodgkin's disease--a single center experience Wiener Klinische Wochenschrift 112(14): 624-628
Arranz, R.; Gil-Fernández, J.J.; Muñoz, E.; Acevedo, A.; Sobrino, M.P.; Fernández-Rañada, J.M. 1998: Outcome of 70 patients diagnosed with Hodgkin's disease after first-line and salvage treatment: experience at one center Sangre 43(3): 179-184
Bladé, J.; Montserrat, E. 1988: What should be done in resistant or relapsing Hodgkin's disease? Medicina Clinica 91(11): 413-415
Krüsmann, W.; Slanina, J.; Boser, F.; Löhr, G.W. 1988: Changes in concentrations of IgM, IgA and IgM immune globulins after megavolt therapy with the large-field technic in patients with Hodgkin's disease Strahlentherapie und Onkologie: Organ der Deutschen Rontgengesellschaft . 164(6): 323-329
Adány, R.; Szegedi, A.; Ablin, R.J.; Muszbek, L. 1988: Fibrinolysis resistant fibrin deposits in lymph nodes with Hodgkin's disease Thrombosis and Haemostasis 60(2): 293-297
István, L.; Balázs, L.; Brittig, F.; Pócza, K.; Szentcsiki, M.; Brenner, F. 1985: Incidence of highly malignant immunoblastic non-Hodgkin lymphoma in patients with Hodgkin's disease in remission Orvosi Hetilap 126(21): 1267-1272
Salloum, E.; Doria, R.; Farber, L.R.; Roberts, K.B.; Cooper, D.L. 1995: Combined modality therapy in previously untreated patients with advanced Hodgkin's disease: a 24-year follow-up study Cancer Journal from Scientific American 1(4): 267-273
Diehl, L.F.; Perry, D.J.; Terebelo, H.; Baldwin, P.E.; Hurwitz, M.; Kimball, D.B.; Dorn, R.V. 1983: Radiation as salvage therapy for patients with Hodgkin's disease relapsing after MOPP (mechlorethamine, vincristine, prednisone, and procarbazine) chemotherapy Cancer Treatment Reports 67(9): 827-829
Gaudin, P.; Rozand, Y.; Fauconnier, J.; Phelip, X. 1995: Rheumatic manifestations at presentation of Hodgkin's disease and non-Hodgkin's malignant lymphoma. A national survey of one hundred forty-six patients Revue du Rhumatisme 62(5): 365-375
Zinzani, P.L.; Martelli, M.; Tura, S.; Mandelli, F. 1993: Granulocyte colony stimulating factor (G-CSF) as adjunct therapy in relapsed-resistant high-grade non-Hodgkin's lymphoma Haematologica 78(1): 40-43
Somers, R.; van Heerde, P. 1983: Non-Hodgkin lymphoma in patients with Hodgkin's disease Nederlands Tijdschrift Voor Geneeskunde 127(2): 55-59
Bonadonna, G.; Valagussa, P.; Santoro, A. 1986: Alternating non-cross-resistant combination chemotherapy or MOPP in stage IV Hodgkin's disease. A report of 8-year results Annals of Internal Medicine 104(6): 739-746
Domingo-Albós, A.; García, J.; Puig, J.; Brunet, S.; Ayats, R.; Pardo, N.; Soler, J.; Muñiz, E.; Badell, I. 1990: Treatment of resistant or relapsing Hodgkin's disease with high doses of chemotherapy followed by autologous bone marrow transplant Medicina Clinica 94(9): 321-324
Venugopal, P.; Das, B.; Sharma, M.L.; Kumar, A.S.; Saxena, N.; Kaul, U. 1989: Our experience with surgical management of patients with diffuse coronary artery disease Indian Heart Journal 41(3): 153-157
Anderlini, P.; Ghaddar, H.M.; Smith, T.L.; Pierce, S.; Kantarjian, H.M.; O'Brien, S.; Keating, M.J.; Freireich, E.J.; Estey, E.H. 1996: Factors predicting complete remission and subsequent disease-free survival after a second course of induction therapy in patients with acute myelogenous leukemia resistant to the first Leukemia 10(6): 964-969
Economopoulos, T.; Stathakis, N.; Alexopoulos, C.; Pavlidis, N.; Constantinidou, M.; Briassoulis, E.; Papageorgiou, E.; Dervenoulas, J.; Pappa, V.; Vaslamatzis, M. 1994: Second malignancies following treatment for Hodgkin's disease: a Greek experience Haematologica 79(3): 273-276
Romano, M.; Libshitz, H.I. 1998: Hodgkin disease and non-Hodgkin lymphoma: plain chest radiographs and chest computed tomography of thoracic involvement in previously untreated patients La Radiologia Medica 95(1-2): 49-53
István, L.; Marton, E. 1989: Experience with a new "reserve protocol" in advanced and pretreated Hodgkin's disease Orvosi Hetilap 130(52): 2791-2796
Cohen, S.M.; Weiner, M.J.; Ratner, L.H.; Greenspan, E.M. 1972: Hodgkin's disease. Recent concepts in management New York State Journal of Medicine 72(17): 2189-2195